Overall, our results in the HFrEF group were very similar to those in the general study population, with the exception of the individual association of the clinical variables with SCD, since only administration of ARB or ACE inhibitors showed predictive value in the HFrEF group. This evidence concerns the gene ACE and Schnyder corneal dystrophy.